Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation
Related Experiment Video
Updated: Jun 26, 2026

Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
Shun Liang1, Nuo Yang, Yue Pan
1Center for Research on the Early Detection and Cure of Ovarian Cancer, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Background:
The Phosphatidylinositol 3'-kinase is a key regulator in various cancer-associated signal transduction pathways. Genetic alterations of its catalytic subunit alpha, PIK3CA, have been identified in ovarian cancer. Our in vivo data suggests that PIK3CA activation is one of the early genetic events in ovarian cancer. However, its role in malignant transformation of ovarian surface epithelium (OSE) is largely unclear.
Methodology/Principal Findings:
Using the Müllerian inhibiting substance type II receptor (MISIIR) promoter, we generated transgenic mice that expressed activated PIK3CA in the Müllerian epithelium. Overexpression of PIK3CA in OSE induced remarkable hyperplasia, but was not able to malignantly transform OSE in vivo. The consistent result was also observed in primary cultured OSEs. Although enforced expression of PIK3CA could not induce OSE anchorage-independent growth, it significantly increased anchorage-independent growth of OSE transformed by mutant K-ras.
Conclusions/Significance:
While PIK3CA activation may not be able to initiate OSE transformation, we conclude that activation of PIK3CA may be an important molecular event contributing to the maintenance of OSE transformation initiated by oncogenes such as K-ras.
Insights
Activation of Phosphatidylinositol 3'-kinase alpha (PIK3CA) alone does not transform ovarian surface epithelium (OSE). However, PIK3CA activation is crucial for maintaining OSE transformation initiated by other oncogenes like K-ras.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Phosphatidylinositol 3 -kinase (PI3K) is a critical regulator in cancer signaling pathways.
- Genetic alterations in PIK3CA, the PI3K catalytic subunit alpha, are observed in ovarian cancer.
- PIK3CA activation is an early event in ovarian cancer, but its role in ovarian surface epithelium (OSE) transformation is unclear.
Purpose of the Study:
- To investigate the role of activated PIK3CA in the malignant transformation of ovarian surface epithelium (OSE).
- To determine if PIK3CA activation can initiate OSE transformation in vivo and in vitro.
Main Methods:
- Generated transgenic mice expressing activated PIK3CA in Müllerian epithelium using the MISIIR promoter.
- Examined OSE hyperplasia and malignant transformation in vivo.
- Assessed anchorage-independent growth in primary cultured OSEs, both alone and in combination with mutant K-ras.
Main Results:
- Overexpression of activated PIK3CA in OSE induced significant hyperplasia but did not lead to malignant transformation.
- Activated PIK3CA alone did not induce anchorage-independent growth in primary OSEs.
- PIK3CA activation significantly enhanced anchorage-independent growth of OSEs already transformed by mutant K-ras.
Conclusions:
- PIK3CA activation is insufficient to initiate OSE malignant transformation.
- PIK3CA activation plays a significant role in maintaining OSE transformation initiated by other oncogenes, such as K-ras.
- This suggests PIK3CA is a key contributor to the progression of ovarian cancer driven by other genetic events.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Oogenesis

